Malaria News and Research

Latest Malaria News and Research

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the PATH Malaria Vaccine Initiative (MVI) to conduct proof-of-concept studies with its proprietary, recombinant vesicular stomatitis virus (rVSV) vector technology as a preventative malaria vaccine.

26 Aug 2009

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of GenVec's vector production technology.

25 Aug 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

A landmark report released today by the Lance Armstrong Foundation (LAF) estimates the total economic burden of new cancer cases at $305 billion in 2009. The findings are included in the report, "Breakaway: The Global Burden of Cancer - Challenges and Opportunities," released today in Dublin at the premiere LIVESTRONG Global Cancer Summit.

25 Aug 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, is accepting grant applications for a new initiative to establish a consortium of human immune profiling research centers.

25 Aug 2009

PLoS journal throws light on neglected tropical diseases toll in sub-Saharan Africa

An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.

25 Aug 2009

Recent releases: limiting corruption; mental health; U.S. global health policies; non-physician administered ARV; African health ministers

A Lancet Infectious Diseases Reflection and Reaction piece says while PEPFAR's "investment of over US$228 million into Mozambique in 2008 alone" resulted in "an exponential increase in the number of people on" ARVs and boosted prevention programs, "[t]here is more money available for HIV/AIDS than can reasonably be spent, especially given Mozambique's poor infrastructure and large geographical area. Unfortunately, one side-effect has been an associated increase in corruption." To maximize aid money and limit corruption, "careful and creative resource management will be needed," the author concludes (Johnson, 9/09).

24 Aug 2009

Foreign aid reform needed 'quickly,' opinion piece says

...

24 Aug 2009

WHO recommends against using homeopathic treatments for HIV, TB, malaria, influenza, infant diarrhea

The WHO has warned that people with conditions such as HIV, tuberculosis and malaria should not rely on homeopathic treatments, the BBC reports. The agency was responding to a June letter (full text available here), in which researchers from the Voice of Young Science Network called on the agency "to condemn the promotion of homeopathy for treating TB, infant diarrhoea, influenza, malaria and HIV."

23 Aug 2009

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

The Miss Universe contestants continued preparations for Sunday night's pageant by competing today in the Condom Olympics - tossing water-filled condoms to test their strength and playing "Wild Fire Infection" games that demonstrate the serious side of HIV infection.

21 Aug 2009

New antimalarial drug discovery project funded by European Commission

The European Commission is funding a two year, -500,000 project to co-ordinate European and international research into the development of new drugs to treat malaria.

21 Aug 2009

WHO Director-General, other officials visit Uganda to assess malaria control efforts

WHO Director-General Margaret Chan arrived in Uganda on Wednesday for a three-day working visit to examine the country's progress on the prevention, control and treatment of malaria, the Monitor reports. Ray Chambers, the U.N. special envoy for malaria, and Tadataka Yamada, president of the Bill & Melinda Gates Foundation's Global Health Program, are traveling with Chan.

20 Aug 2009

NYT Magazine interviews Clinton on global women's issues

The New York Times Magazine, as part of a special issue that focuses on women worldwide, published an interview with Secretary of State Hillary Rodham Clinton who "staked her claim as an advocate for global women's issues in 1995, when, as first lady, she gave an impassioned speech at a United Nations conference in Beijing." The interview was conducted ahead of her 11-day, seven country tour of Africa.

20 Aug 2009

Cambodia's maternal mortality; drugs in Uganda; cholera risk in Zimbabwe; HIV laws in Niger

A lack of outreach by public health officials and rural villagers' preference for traditional midwives have hindered efforts to reduce maternal morality in Cambodia, government officials said recently at regional conference, the Phnom Penh Post reports.

20 Aug 2009

Some HIV-positive Ugandans' not receiving antiretrovirals

Some HIV-positive people in Uganda "cannot be put on the national antiretroviral [ARV] programme because it is already saturated and funds for new patients are not available," the Independent reports. According to the newspaper, roughly 360,000 HIV-positive Ugandans are eligible for antiretroviral treatment because their CD4 counts are below the WHO's threshold of 350; however, about half of them currently do not have access to ARVs.

20 Aug 2009

Newly joined Vice President to provide leadership for IAVI's fundraising strategy

Dianne Stewart, former head of Board and Donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Resource Development. In her role at IAVI, Ms. Stewart will provide leadership for the organization’s fundraising strategy focused on both the public and private sectors.

20 Aug 2009

The Gambia introduces pneumococcal immunisation programme

The Gambia, Minister of Health Dr. Mariatou Jallow administered the first dose of the pneumococcal vaccine to Gambian children at a rural clinic outside Banjul today. Joined by the Gambia’s Vice President, Mrs. Isatou Njie-Saidy, Dr. Jallow and hundreds of Gambian citizens celebrated this historic event, which marks the first step in the rollout of the Gambia’s national pneumococcal immunisation programme.

19 Aug 2009

Global Fund awards Tanzania $111 million grant for ITNs

Tanzania will receive an $111 million grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria for insecticide-treated nets (ITNs) to be used in the country's fight against malaria, Ray Chambers, U.N. special envoy for malaria, said at a meeting in Dar es Salaam, Tanzania, on Monday, Reuters reports.

19 Aug 2009

Opinion: Chronic disease in Africa; education can help combat disease; climate change and health; TB vaccine

"An epidemic of chronic, non-communicable diseases such as heart disease, mental illness, cancer, diabetes, and obesity is growing in Africa, a continent still struggling with infectious and nutritional diseases," according to a Boston Globe opinion piece by Michelle Holmes and Shona Dalal.

18 Aug 2009

New consortium to tackle African sleeping sickness and Leishmaniasis

A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and Leishmaniasis, which affect millions of people worldwide.

17 Aug 2009

New microneedle-based injection device from Nanopass

Following the World Health Organization (WHO) declaration of a swine flu pandemic, NanoPass Technologies Ltd. (NanoPass) announced today that it has successfully developed a microneedle-based injection device that could dramatically enhance both the effectiveness and supply of pandemic flu vaccines.

14 Aug 2009

Malaria News and Research

Latest Malaria News and Research

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

PLoS journal throws light on neglected tropical diseases toll in sub-Saharan Africa

Recent releases: limiting corruption; mental health; U.S. global health policies; non-physician administered ARV; African health ministers

Foreign aid reform needed 'quickly,' opinion piece says

WHO recommends against using homeopathic treatments for HIV, TB, malaria, influenza, infant diarrhea

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

New antimalarial drug discovery project funded by European Commission

WHO Director-General, other officials visit Uganda to assess malaria control efforts

NYT Magazine interviews Clinton on global women's issues

Cambodia's maternal mortality; drugs in Uganda; cholera risk in Zimbabwe; HIV laws in Niger

Some HIV-positive Ugandans' not receiving antiretrovirals

Newly joined Vice President to provide leadership for IAVI's fundraising strategy

The Gambia introduces pneumococcal immunisation programme

Global Fund awards Tanzania $111 million grant for ITNs

Opinion: Chronic disease in Africa; education can help combat disease; climate change and health; TB vaccine

New consortium to tackle African sleeping sickness and Leishmaniasis

New microneedle-based injection device from Nanopass

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in